Trade Q32 Bio Inc - QTTB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0205 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.8981 |
| Open | 0.8971 |
| 1-Year Change | -0.23% |
| Day's Range | 0.8971 - 0.9671 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | 0.9171 | 0.0199 | 2.22% | 0.8972 | 0.9695 | 0.8971 |
| Mar 22, 2024 | 0.8981 | 0.0294 | 3.38% | 0.8687 | 0.9321 | 0.8537 |
| Mar 21, 2024 | 0.8819 | 0.0138 | 1.59% | 0.8681 | 0.8922 | 0.8671 |
| Mar 20, 2024 | 0.8931 | 0.0145 | 1.65% | 0.8786 | 0.9170 | 0.8571 |
| Mar 19, 2024 | 0.8973 | -0.0098 | -1.08% | 0.9071 | 0.9322 | 0.8783 |
| Mar 18, 2024 | 0.8973 | 0.0002 | 0.02% | 0.8971 | 0.9021 | 0.8651 |
| Mar 15, 2024 | 0.9171 | 0.0000 | 0.00% | 0.9171 | 0.9251 | 0.9071 |
| Mar 14, 2024 | 0.9171 | 0.0100 | 1.10% | 0.9071 | 0.9501 | 0.9071 |
| Mar 13, 2024 | 0.9071 | 0.0300 | 3.42% | 0.8771 | 0.9071 | 0.8771 |
| Mar 12, 2024 | 0.8946 | 0.0175 | 2.00% | 0.8771 | 0.8971 | 0.8771 |
| Mar 11, 2024 | 0.9069 | 0.0298 | 3.40% | 0.8771 | 0.9069 | 0.8771 |
| Mar 8, 2024 | 0.8869 | -0.0003 | -0.03% | 0.8872 | 0.8981 | 0.8771 |
| Mar 7, 2024 | 0.8995 | -0.0070 | -0.77% | 0.9065 | 0.9071 | 0.8471 |
| Mar 6, 2024 | 0.8971 | 0.0300 | 3.46% | 0.8671 | 0.8971 | 0.8671 |
| Mar 5, 2024 | 0.8669 | -0.0102 | -1.16% | 0.8771 | 0.8874 | 0.8585 |
| Mar 4, 2024 | 0.8917 | -0.0083 | -0.92% | 0.9000 | 0.9000 | 0.8640 |
| Mar 1, 2024 | 0.8931 | -0.0369 | -3.97% | 0.9300 | 0.9400 | 0.8800 |
| Feb 29, 2024 | 0.9200 | 0.0189 | 2.10% | 0.9011 | 0.9300 | 0.8828 |
| Feb 28, 2024 | 0.9200 | 0.0013 | 0.14% | 0.9187 | 0.9348 | 0.8960 |
| Feb 27, 2024 | 0.9150 | 0.0230 | 2.58% | 0.8920 | 0.9194 | 0.8700 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Homology Medicines Company profile
About Homology Medicines Inc
Homology Medicines, Inc. is a clinical-stage genetic medicines company. The Company focuses on patients suffering from rare genetic diseases by curing the underlying cause of the disease. Its platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs), to deliver single administration genetic medicines in vivo either through gene therapy or nuclease-free gene editing across a range of genetic disorders. Its various set of AAVHSCs allows it to target, via a single injection, a range of disease-relevant tissues, including the liver, central nervous system (CNS), peripheral nervous system (PNS), bone marrow, muscle and eye. Its lead product candidate, HMI-102, is a gene therapy for the treatment of adults with phenylketonuria (PKU). Its other gene therapy product development candidates for the treatment of lysosomal storage diseases are HMI-203, for the treatment of mucopolysaccharidosis type II (MPS II) and HMI-202.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Homology Medicines Inc revenues increased from $1.7M to $33.2M. Net loss decreased 37% to $62.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development - Balancing val decrease of 13% to $63.1M (expense), General and administrative - Balancing decrease of 1% to $19.8M (expense).
| Industry: | Bio Therapeutic Drugs |
1 Patriots Park
BEDFORD
MASSACHUSETTS 01730-2343
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com